This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Telix Pharmaceuticals has entered an agreement to add Subtle Medical’s AI software for enhancing prostate-specific membrane antigen (PSMA) PET prostate cancer scans to its product portfolio. SubtlePET is a U.S.
The facility will provide much needed developmental and manufacturing support for pharmaceutical companies that produce and distribute medical isotopes.
Bankes has 30 years of experience in product management, marketing, sales, regulatory, medical affairs, and operations and manufacturing, GEHC said. Patient Care Solutions is one of GEHCs four individual segments, along with Imaging, Advanced Visualization Solutions, and Pharmaceutical Diagnostics.
milla1cf Tue, 01/23/2024 - 13:50 January 23, 2024 — Bayer announced Nelson Ambrogio as the new Head of the Radiology Business at its Pharmaceuticals Division, effective April 1, 2024. He will report to Stefan Oelrich , Member of the Board of Management, Bayer AG, and President Pharmaceuticals.
Fusion Pharmaceuticals announced a patent dispute settlement and new licensing agreement with Heidelberg University and Euratom for exclusive, worldwide rights to their existing patent for FPI-2265, an actinium-225-based targeted radiotherapy for the treatment of prostate-specific membrane antigen (PSMA)-expressing cancers.
Telix Pharmaceuticals is highlighting that the first patient has been dosed with the company's TLX250-CDx (Zr-89 DFO-girentuximab) for clear cell renal cell carcinoma, the most common and aggressive form of kidney cancer.
NorthStar Medical Radioisotopes is routinely manufacturing copper-67(Cu-67. Read more on AuntMinnie.com Related Reading: NorthStar appoints new president/CEO NorthStar installs accelerator at its new Wisc.
Telix Pharmaceuticals has entered a $20 million agreement to acquire th. Read more on AuntMinnie.com Related Reading: First patient dosed in phase II Telix Starburst trial Telix acquires Dedicaid for $1.2M
mtaschetta-millane Thu, 07/25/2024 - 08:50 July 25, 2024 — NorthStar Medical Radioisotopes, LLC and BWXT Medical Ltd. , Medical isotopes are essential for a wide range of diagnostic and therapeutic procedures, including cancer treatments and advanced imaging techniques. a subsidiary of BWX Technologies, Inc.
milla1cf Wed, 09/20/2023 - 09:56 September 20, 2023 — RefleXion Medical , Inc., We look forward to working with RefleXion and their collaborator network to bring this project to fruition.”
Delphinus Medical Technologies , developer of SoftVue Breast Tomographic Ultrasound, has named Michael Emery as the company's chief financial officer (CFO). Emery has more than 30 years of experience in financial executive leadership in the pharmaceutical and medical device industries.
Read on for our views on how standardized, adaptable infrastructure for medical imaging AI will ultimately improve the efficiency and precision of radiological assessments. AI can be leveraged to make incremental improvements at every stage of the medical imaging pipeline, beyond the tasks well-suited for a large language model.
Lantheus Medical Imaging has appointed a new chief medical officer (CMO) and a new chief science officer (CSO). He will oversee Lantheus’ research and development organization, including research and pharmaceutical development, regulatory affairs, clinical development, medical affairs, and isotope strategy.
Understand options for natural and medical solutions to get healthy nails. The post Natural Vs. Pharmaceutical Fungal Nail Treatments: Whats Best For Australians? Find out everything about fungal nail treatments. appeared first on Open MedScience.
Carestream Health has secured a distribution contract for its radiology, cardiology, urology, endoscopy, and pharmaceutical offerings with BSF Medical - SARL of Bir El Djir, Algeria. BSF Medical - SARL is one of Algeria's largest medical equipment distributors in both public and private sectors, Carestream said.
Administration of the therapeutic dose took place as part of an ongoing Phase I/IIa theranostic clinical trial conducted by Clarity Pharmaceuticals to investigate the safety and efficacy of Cu-67 SARTATE in pediatric patients with high-risk neuroblastoma.
NorthStar Medical Radioisotopes has launched its new radiopharmaceutical Contract Development and Manufacturing (CDMO) facility on its campus in Beloit, WI.
milla1cf Mon, 06/19/2023 - 19:27 June 19, 2023 — NorthStar Medical Technologies, LLC , a global innovator in the development, production and commercialization of radiopharmaceuticals used for therapeutic applications and medical imaging, today announced the appointment of Frank Scholz, Ph.D., He holds a Ph.D.
NorthStar Medical Isotopes will supply Bayer with the medical radioisotope actinium-22. Read more on AuntMinnie.com Related Reading: NorthStar manufactures Cu-67 for Clarity Pharmaceuticals NorthStar appoints new president/CEO NorthStar installs accelerator at its new Wisc.
With her large experience in the pharmaceutical industry, Helen Blanco currently serves as Chief Operating Officer at Node Pharma , a preclinical radiopharmaceutical company based in Norway. Here is another excerpt from our conversation.
Telix Pharmaceuticals reported a spike in revenue for the first half of 2023. Read more on AuntMinnie.com Related Reading: Telix doses first patient in Chinese prostate cancer trial Telix to acquire Lightpoint Medical for $20M First patient dosed in phase II Telix Starburst trial Telix acquires Dedicaid for $1.2M
Telix Pharmaceuticals said the first patient has been dosed in a trial in Chin. Read more on AuntMinnie.com Related Reading: Telix to acquire Lightpoint Medical for $20M First patient dosed in phase II Telix Starburst trial Telix acquires Dedicaid for $1.2M
milla1cf Mon, 04/24/2023 - 14:10 April 24, 2023 — - NorthStar Medical Radioisotopes , LLC, a global innovator in the development, production and commercialization of radiopharmaceuticals used for therapeutic and medical imaging applications, has announced the appointment of Jean-Noel David , MBA, MS, as Vice President, Operations.
Vinyard spent 16 years in roles of increasing responsibility at Mallinckrodt/Curium, where he was most recently Global Director of Business Development for Curium’s Active Pharmaceutical Ingredient business and held responsibility for a considerable portion of its U.S. SPECT franchise.
Eliot Siegel, MD; Stanislav Spiridonov, MD; Nathan Gee, MD; and Anthony Chang, PhD, are among a niche gathering of early adopters, entrepreneurial physicians, medical physicists, and investors with a sweet spot for nuclear medicine, diagnostic radiology, and radiation oncology.
The end-to-end care continuum is designed to support clinicians and promote developments for lung health in the pharmaceutical and medical device industries. will unveil its lung care continuum at the ASCO annual meeting. It features AI tools that identify, measure, manage, and monitor lung health developments.
Clarity Pharmaceuticals has secured fast-track designation from the U.S. The FDA's fast-track designation is designed to expedite the development and regulatory review of novel drugs addressing serious conditions with significant unmet medical needs.
NorthStar’s industry-leading reputation is grounded in technological innovation, successful execution and proven expertise, and we have made tremendous strides in advancing our portfolio over the past year,” said Stephen Merrick , Chief Executive Officer of NorthStar Medical Radioisotopes. imaging studies daily.
"By not separating radiologist assistant reimbursement policies into different payment categories by service location, the adoption of MARCA would enable radiologists to devote more focused time to reviewing and interpreting complex medical images or urgent cases," the ASRT has said. Creating pressure, the U.S.
Food and Drug Administration (FDA), includes stakeholders and experts from across the pharmaceutical industry and academia. Through the partnership, autoRECIST will address the need for automating and standardizing tumor response assessments in medical imaging to improve cancer treatment and research.
Lu-177 is a medical radioisotope frequently used in radiopharmaceutical therapy to treat cancer. This is a mandatory process needed to obtain pharmaceutical manufacturing authorization. ITM said with the RAM license and other regulatory approvals, the company has achieved operational readiness.
Originally started as an executive recruiting firm focused on the pharmaceutical industry, it quickly evolved into an IT recruiting firm with a strong focus on Cyber Security. He also worked in the telecom/Internet industry for McLeod USA, as well as a Pharmaceutical rep for Sepracor in Minneapolis, MN.
Global pharmaceutical firm UCB developed IB Lab Flamingo's deep-learning computational model which is being integrated into the family of IB Lab Zoo orthopedic AI software modules designed to automatically analyze and extract key disease parameters that are critical for the prevention and treatment of various musculoskeletal conditions.
Finally, respondent hospitals reported the following additional difficulties faced during the war: supply chain disruptions for essential equipment and pharmaceuticals, laboratory test kit shortages, delays in the delivery of crucial medications, and power outages causing problems for appropriate medication storage.
Spending time on electronic medical record (EMR) system order sets early will translate into higher reimbursement. Centers for Medicare and Medicaid (CMS) and manufacturers that agree to provide pharmaceuticals at significantly reduced rates for facilities that qualify.
PanTera is committed to supporting the pharmaceutical industry by scaling up production to meet the significant global demand for targeted radiopharma-based therapeutics in the fight against cancer.”
With her large experience in the pharmaceutical industry, Helen Blanco currently serves as Chief Operating Officer at Node Pharma , a preclinical radiopharmaceutical company based in Norway. We recently spoke with Helen about the key criteria when selecting an imaging vendor and exciting upcoming innovations in the oncology space.
The Evanston, IL-based company specializes in delivering dosimetry analysis and treatment plans to clinical research organizations and pharmaceutical manufacturers. The company offers scalable dosimetry services that integrate with existing imaging workflows in hospitals and cancer treatment research facilities.
Radiopharmaceuticals, combining radioactive and pharmaceutical elements, enable precise diagnosis and treatment in nuclear medicine. The post The Transformative Impact of Radiopharmaceuticals in Medical Imaging appeared first on Open Medscience.
As a rare alpha-emitting medical radioisotope, 225Ac is quickly gaining attention across the precision oncology field due to its significant potential as a powerful new weapon in the fight against cancer. Targeted alpha therapy is attracting growing interest from scientists and medical practitioners.
The project is the second funded and supported by NEURii, a global collaboration between the pharmaceutical company Eisai, Gates Ventures, the University of Edinburgh, the medical research charity LifeArc and the national health data science institute Health Data Research UK.
The need for more remotely accessible services like telemedicine and a range of advanced medical devices is accelerating growth across the industry. Recent reports highlight that the MedTech (medical technology) industry is set to grow to a value of $595 billion in 2024. Medical Device Sales: Which Devices Are Driving Industry Growth?
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content